315 related articles for article (PubMed ID: 25053719)
1. Increased risk of serious bacterial infections due to maternal immunosuppression in HIV-exposed uninfected infants in a European country.
Taron-Brocard C; Le Chenadec J; Faye A; Dollfus C; Goetghebuer T; Gajdos V; Labaune JM; Perilhou A; Mandelbrot L; Blanche S; Warszawski J;
Clin Infect Dis; 2014 Nov; 59(9):1332-45. PubMed ID: 25053719
[TBL] [Abstract][Full Text] [Related]
2. Morbidity among human immunodeficiency virus-exposed but uninfected, human immunodeficiency virus-infected, and human immunodeficiency virus-unexposed infants in Zimbabwe before availability of highly active antiretroviral therapy.
Koyanagi A; Humphrey JH; Ntozini R; Nathoo K; Moulton LH; Iliff P; Mutasa K; Ruff A; Ward B;
Pediatr Infect Dis J; 2011 Jan; 30(1):45-51. PubMed ID: 21173675
[TBL] [Abstract][Full Text] [Related]
3. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.
Connor EM; Sperling RS; Gelber R; Kiselev P; Scott G; O'Sullivan MJ; VanDyke R; Bey M; Shearer W; Jacobson RL
N Engl J Med; 1994 Nov; 331(18):1173-80. PubMed ID: 7935654
[TBL] [Abstract][Full Text] [Related]
4. Growth of infants born to HIV-infected women in South Africa according to maternal and infant characteristics.
Venkatesh KK; Lurie MN; Triche EW; De Bruyn G; Harwell JI; McGarvey ST; Gray GE
Trop Med Int Health; 2010 Nov; 15(11):1364-74. PubMed ID: 20955499
[TBL] [Abstract][Full Text] [Related]
5. Infectious disease morbidity among young HIV-1-exposed but uninfected infants in Latin American and Caribbean countries: the National Institute of Child Health and Human Development International Site Development Initiative Perinatal Study.
Mussi-Pinhata MM; Freimanis L; Yamamoto AY; Korelitz J; Pinto JA; Cruz ML; Losso MH; Read JS;
Pediatrics; 2007 Mar; 119(3):e694-704. PubMed ID: 17296782
[TBL] [Abstract][Full Text] [Related]
6. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.
Sperling RS; Shapiro DE; Coombs RW; Todd JA; Herman SA; McSherry GD; O'Sullivan MJ; Van Dyke RB; Jimenez E; Rouzioux C; Flynn PM; Sullivan JL
N Engl J Med; 1996 Nov; 335(22):1621-9. PubMed ID: 8965861
[TBL] [Abstract][Full Text] [Related]
7. Initiation of Antiretroviral Therapy Before Pregnancy Reduces the Risk of Infection-related Hospitalization in Human Immunodeficiency Virus-exposed Uninfected Infants Born in a High-income Country.
Goetghebuer T; Smolen KK; Adler C; Das J; McBride T; Smits G; Lecomte S; Haelterman E; Barlow P; Piedra PA; van der Klis F; Kollmann TR; Lauffenburger DA; Alter G; Levy J; Marchant A
Clin Infect Dis; 2019 Mar; 68(7):1193-1203. PubMed ID: 30215689
[TBL] [Abstract][Full Text] [Related]
8. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
; de Vincenzi I
Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718
[TBL] [Abstract][Full Text] [Related]
9. In Utero Exposure to Antiretroviral Drugs: Effect on Birth Weight and Growth Among HIV-exposed Uninfected Children in Brazil.
Hofer CB; Keiser O; Zwahlen M; Lustosa CS; Frota AC; de Oliveira RH; Abreu TF; Carvalho AW; Araujo LE; Egger M
Pediatr Infect Dis J; 2016 Jan; 35(1):71-7. PubMed ID: 26741583
[TBL] [Abstract][Full Text] [Related]
10. Reduced mother-to-child transmission of HIV associated with infant but not maternal GB virus C infection.
Supapol WB; Remis RS; Raboud J; Millson M; Tappero J; Kaul R; Kulkarni P; McConnell MS; Mock PA; Culnane M; McNicholl J; Roongpisuthipong A; Chotpitayasunondh T; Shaffer N; Butera S
J Infect Dis; 2008 May; 197(10):1369-77. PubMed ID: 18419578
[TBL] [Abstract][Full Text] [Related]
11. Maternal factors associated with perinatal HIV-1 transmission: the French Cohort Study: 7 years of follow-up observation. The French Pediatric HIV Infection Study Group.
Mayaux MJ; Blanche S; Rouzioux C; Le Chenadec J; Chambrin V; Firtion G; Allemon MC; Vilmer E; Vigneron NC; Tricoire J
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Feb; 8(2):188-94. PubMed ID: 7834401
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team.
Mofenson LM; Lambert JS; Stiehm ER; Bethel J; Meyer WA; Whitehouse J; Moye J; Reichelderfer P; Harris DR; Fowler MG; Mathieson BJ; Nemo GJ
N Engl J Med; 1999 Aug; 341(6):385-93. PubMed ID: 10432323
[TBL] [Abstract][Full Text] [Related]
13. Management of human immunodeficiency virus-infected pregnant women at Latin American and Caribbean sites.
Read JS; Cahn P; Losso M; Pinto J; Joao E; Duarte G; Cardoso E; Freimanis-Hance L; Stoszek SK;
Obstet Gynecol; 2007 Jun; 109(6):1358-67. PubMed ID: 17540808
[TBL] [Abstract][Full Text] [Related]
14. Morbidity and mortality among a cohort of human immunodeficiency virus type 1-infected and uninfected pregnant women and their infants from Malawi, Zambia, and Tanzania.
Chilongozi D; Wang L; Brown L; Taha T; Valentine M; Emel L; Sinkala M; Kafulafula G; Noor RA; Read JS; Brown ER; Goldenberg RL; Hoffman I;
Pediatr Infect Dis J; 2008 Sep; 27(9):808-14. PubMed ID: 18679152
[TBL] [Abstract][Full Text] [Related]
15. Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV.
Palombi L; Marazzi MC; Voetberg A; Magid NA
AIDS; 2007 Jul; 21 Suppl 4():S65-71. PubMed ID: 17620755
[TBL] [Abstract][Full Text] [Related]
16. Viral studies of mothers with human immunodeficiency virus infection at delivery and their infants in the first 3 days of life.
Sison AV; Brandt CD; Rakusan TA; Wientzen R; Fuccillo DA; Sever JL
Pediatr AIDS HIV Infect; 1996 Oct; 7(5):325-30. PubMed ID: 11361490
[TBL] [Abstract][Full Text] [Related]
17. Impact of maternal HIV-1 viremia on lymphocyte subsets among HIV-exposed uninfected infants: protective mechanism or immunodeficiency.
Kakkar F; Lamarre V; Ducruet T; Boucher M; Valois S; Soudeyns H; Lapointe N
BMC Infect Dis; 2014 May; 14():236. PubMed ID: 24885498
[TBL] [Abstract][Full Text] [Related]
18. Impact of elevated maternal HIV viral load at delivery on T-cell populations in HIV exposed uninfected infants in Mozambique.
de Deus N; Moraleda C; Serna-Bolea C; Renom M; Menendez C; Naniche D
BMC Infect Dis; 2015 Feb; 15():37. PubMed ID: 25645120
[TBL] [Abstract][Full Text] [Related]
19. Missed opportunities for perinatal HIV prevention among HIV-exposed infants born 1996-2000, pediatric spectrum of HIV disease cohort.
Peters V; Liu KL; Dominguez K; Frederick T; Melville S; Hsu HW; Ortiz I; Rakusan T; Gill B; Thomas P
Pediatrics; 2003 May; 111(5 Pt 2):1186-91. PubMed ID: 12728136
[TBL] [Abstract][Full Text] [Related]
20. Maternal Tenofovir Disoproxil Fumarate Use in Pregnancy and Growth Outcomes among HIV-Exposed Uninfected Infants in Kenya.
Pintye J; Langat A; Singa B; Kinuthia J; Odeny B; Katana A; Nganga L; John-Stewart G; McGrath CJ
Infect Dis Obstet Gynecol; 2015; 2015():276851. PubMed ID: 26823647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
